GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Ananda Developments PLC (STU:1FX) » Definitions » Sloan Ratio %

Ananda Developments (STU:1FX) Sloan Ratio % : 0.00% (As of Jul. 2023)


View and export this data going back to 2022. Start your Free Trial

What is Ananda Developments Sloan Ratio %?

Richard Sloan from the University of Michigan was first to document what is referred to as the "accrual anomaly". His 1996 paper found that shares of companies with small or negative accruals vastly outperform (+10%) those of companies with large ones.

Ananda Developments's Sloan Ratio for the quarter that ended in Jul. 2023 was 0.00%.

As of Jul. 2023, Ananda Developments has a Sloan Ratio of 0.00%, indicating the company is in the safe zone and there is no funny business with accruals.


Ananda Developments Sloan Ratio % Historical Data

The historical data trend for Ananda Developments's Sloan Ratio % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ananda Developments Sloan Ratio % Chart

Ananda Developments Annual Data
Trend Jan19 Jan20 Jan21 Jan22 Jan23
Sloan Ratio %
79.68 - - - 9.27

Ananda Developments Semi-Annual Data
Jul18 Jan19 Jul19 Jan20 Jul20 Jan21 Jul21 Jan22 Jul22 Jan23 Jul23
Sloan Ratio % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Ananda Developments's Sloan Ratio %

For the Drug Manufacturers - Specialty & Generic subindustry, Ananda Developments's Sloan Ratio %, along with its competitors' market caps and Sloan Ratio % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Ananda Developments's Sloan Ratio % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Ananda Developments's Sloan Ratio % distribution charts can be found below:

* The bar in red indicates where Ananda Developments's Sloan Ratio % falls into.



Ananda Developments Sloan Ratio % Calculation

Earnings contain a lot of non cash earnings which is called accruals. The Sloan ratio is a way to identify firms with low non-cash or accrual-derived earnings relative to their cash flow.

Ananda Developments's Sloan Ratio for the fiscal year that ended in Jan. 2023 is calculated as

Sloan Ratio=(Net Income (A: Jan. 2023 )-Cash Flow from Operations (A: Jan. 2023 )
-Cash Flow from Investing (A: Jan. 2023 ))/Total Assets (A: Jan. 2023 )
=(-1.478--0.519
--1.644)/7.393
=9.27%

Ananda Developments's Sloan Ratio for the quarter that ended in Jul. 2023 is calculated as

Sloan Ratio=(Net Income (TTM)-Cash Flow from Operations (TTM))
-Cash Flow from Investing (TTM))/Total Assets (Q: Jul. 2023 )
=(-2.255-0
-0)/9.054
=-24.91%

For company reported semi-annually, GuruFocus uses latest two semi-annual data as the TTM data. Ananda Developments's Net Income for the trailing twelve months (TTM) ended in Jul. 2023 was -1.102 (Jan. 2023 ) + -1.153 (Jul. 2023 ) = €-2.26 Mil.
Ananda Developments's Cash Flow from Operations for the trailing twelve months (TTM) ended in Jul. 2023 was 0 (Jan. 2023 ) + 0 (Jul. 2023 ) = €0.00 Mil.
Ananda Developments's Cash Flow from Investing for the trailing twelve months (TTM) ended in Jul. 2023 was 0 (Jan. 2023 ) + 0 (Jul. 2023 ) = €0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Ananda Developments  (STU:1FX) Sloan Ratio % Explanation

A former University of Michigan researcher, Richard Sloan's 1996 paper found that shares of companies with small or negative accruals vastly outperform (+10%) those of companies with large ones. In fact, for the 40-year period between 1962 and 2001, buying the lowest accrual companies and shorting the highest accrual companies resulted in an average annual compounded return of 18%, more than double the S&P 500's 7.4% annual return over the same period.

According to How to Beat the Market with the Sloan Ratio:

If the Sloan Ratio is between -10% and 10%, the company is in the safe zone and there is no funny business with accruals.

If the Sloan Ratio is less than between -25% and -10% on the negative side, and between 10% and 25% on the positive side, this is a warning stage of accrual build up.

If the Sloan Ratio is less than -25% or greater than 25%, and this ratio is consistent over several quarters or even years, be careful. Earnings are highly likely to be made up of accruals.

As of Jul. 2023, Ananda Developments has a Sloan Ratio of 0.00%, indicating the company is in the safe zone and there is no funny business with accruals.


Ananda Developments Sloan Ratio % Related Terms

Thank you for viewing the detailed overview of Ananda Developments's Sloan Ratio % provided by GuruFocus.com. Please click on the following links to see related term pages.


Ananda Developments Business Description

Traded in Other Exchanges
N/A
Address
60 Gracechurch Street, 6th Floor, London, GBR, EC3V 0HR
Ananda Developments PLC provides investment to healthcare market for the companies that develop medicinal or therapeutic cannabis derivatives, or related products including nutraceuticals, dietary supplements, and cosmetic products which contain Cannabis or hemp derived cannabinoids.

Ananda Developments Headlines

No Headlines